Acic Cold Sore 5% w/w Cream
Authorisation PA0711/017/006 · Rowex Ltd
- Licence holder
- Rowex Ltd (all products →)
- Active substance
- Aciclovir
- Dosage form
- Cream
- Route of administration
- Cutaneous use
- ATC codes
- D06BB, D06BB03
- First authorised
- 23/11/2012
- Prescription status
- Product not subject to medical prescription
- Supply
- Supply through non-pharmacy outlets and pharmacies
- Legal basis
- Informed consent application (Article 10c of Directive No 2001/83/EC)
Aciclovir: supply and approvals
18 authorised products on the HPRA list contain Aciclovir. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 20 Nov 2026)
- Germany (BfArM)
- 3 supply notices, e.g. Aciclovir-ratiopharm 50 mg/g Creme (16 Feb 2026 to 29 Mar 2027)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 13 years (since 23 November 2012). The HPRA list marks it as marketed in Ireland.
Other medicines with Aciclovir in Ireland
17 other products on the HPRA list contain Aciclovir, from 13 licence holders; 9 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Aciclovir 200 mg/5ml Oral Suspension | Syri Pharma Limited t/a Thame Laboratories | National authorisation (PA) | Marketed |
| Aciclovir 25mg/ml concentrate for solution for infusion | Pfizer Healthcare Ireland Unlimited Company | National authorisation (PA) | Marketed |
| Aciclovir Agepha 30 mg/g eye ointment | AGEPHA Pharma s.r.o. | National authorisation (PA) | Marketed |
| Aciclovir Azevedos 250 mg Powder for solution for infusion | Laboratórios Azevedos - Indústria Farmacêutica S.A | National authorisation (PA) | Marketed |
| Viralief 50 mg/g Cream | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Zovirax 200 mg Dispersible Tablets | GlaxoSmithKline (Ireland) Limited | National authorisation (PA) | Marketed |
| Zovirax 200 mg/5 mL Oral Suspension | GlaxoSmithKline (Ireland) Limited | National authorisation (PA) | Marketed |
| Zovirax Cold Sore 5% w/w Cream | Haleon Ireland Limited | National authorisation (PA) | Marketed |
| Zovirax IV for Infusion 250 mg, Powder for solution for infusion | GlaxoSmithKline (Ireland) Limited | National authorisation (PA) | Marketed |
| Acic 5% Cream | Rowex Ltd | National authorisation (PA) | Not marketed |
| Aciclovir 250 mg powder for solution for infusion | Noridem Enterprises Limited | National authorisation (PA) | Not marketed |
| Aciclovir 25mg/ml Concentrate for solution for infusion | Baxter Holding B.V. | National authorisation (PA) | Not marketed |
Other substances in ATC group D06BB
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 7 other active substances share the group D06BB with this product:
Imiquimod (2) · Green tea dry extract (1) · Penciclovir (1) · Podophyllotoxin (1) · Acyclovir (1) · ACICLOVIR PH. EUR. (1) · HYDROCORTISONE PH. EUR. (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Rowex Ltd holds 24 products on the HPRA list, with 17 different active substances; 19 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.